Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
08:50 - 09:00

Chairperson’s Opening Remarks

More
Showing of Streams
10:30 - 11:15

Morning Coffee

More
Showing of Streams
12:45 - 14:00

Lunch and Networking

More
Showing of Streams
15:30 - 16:00

Afternoon Coffee

More
Showing of Streams
17:00 - 17:05
End of Day Two

End of Day Two

More
08:50 - 09:00 10 mins
Chairperson’s Opening Remarks
09:00 - 09:30 30 mins
Regional Spotlight Session - Case Studies and Pipeline Updates
Adoptive Cell Therapy with Gene-engineered T-cells - Specificity, Construct, and Cells
  • Hiroshi Shiku - Professor, Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine , Japan
09:30 - 10:00 30 mins
Regional Spotlight Session - Case Studies and Pipeline Updates
Basic technologies for CAR-T cell therapy (tentative)
  • Keiya Ozawa - Director, Center for Gene & Cell Therapy - Professor, Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo
10:00 - 10:30 30 mins
Regional Spotlight Session - Case Studies and Pipeline Updates
Spotlight Session
10:30 - 11:15 45 mins
Morning Coffee
11:15 - 11:45 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – Japan
hES Case Study
  • Hideto Yamaguchi - Executive Director, Head of Technical Operations, Astellas Institute for Regenerative Medicine (AIRM)
11:45 - 12:15 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – Japan
MSC Case Study
  • Ting He - CEO, ImmunoChina Pharmaceuticals Co, Ltd., China
12:15 - 12:45 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – Japan
Spotlight Presentation
12:45 - 14:00 75 mins
Lunch and Networking
14:00 - 14:30 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – China
TriCAR-T / gp100 program for the treatment of melanoma – case study
  • Peter Sun - Head of Global Partnering, Beike Biotech Ltd.,, CEO, Timmune, China
14:30 - 15:00 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – China
Spotlight Presentation
15:00 - 15:30 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – China
Ex vivo NK expansion without allogeneic feeder cells, viral factors, and non-human components
  • James Chieh-Liang - Deputy Director, Science and Innovation Department, MedigenBiotechnologyCorp
15:30 - 16:00 30 mins
Afternoon Coffee
16:00 - 16:30 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – China cntd. And Rest of Asia
Stem Cell Case Study
  • Steve Oh - Institute Professor & Scientist, Bioprocessing Technology Institute
16:30 - 17:00 30 mins
Regional Spotlight Session – Case Studies and Pipeline Updates – China cntd. And Rest of Asia
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
  • Koji Tamada - Professor and Chairman, Department of Immunology, Yamaguchi University Graduate School of Medicine, Japan
17:00 - 17:05 5 mins
End of Day Two